TY - JOUR
T1 - Altered expression of transforming growth factor-β1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix
AU - Comerci, John T.
AU - Runowicz, Carolyn D.
AU - Flanders, Kathleen C.
AU - De Victoria, Carol
AU - Fields, Abbie L.
AU - Kadish, Anna S.
AU - Goldberg, Gary L.
PY - 1996/3/15
Y1 - 1996/3/15
N2 - BACKGROUND. Transforming growth factor-β1 (TGF-β1) is a potent growth inhibitor of epithelial cell growth, but can also stimulate stromal cell growth. Loss of responsiveness to TGF-β1 or loss of TGF-β1 itself may be important in the progression of cervical intraepithelial neoplasia (CIN) to invasive cervical carcinoma. METHODS. To examine the expression of TGF-β in early stages of malignant transformation of the uterine cervix, paraffin embedded tissue samples from 11 patients with normal cervical epithelium, 15 with CIN I-III, 12 with microinvasive, and 18 with invasive squamous cell carcinoma were examined using an immunohistochemical technique. Tissues were immunostained with polyclonal antibodies that react with intracellular and extracellular forms of TGF-β1. RESULTS. Percent positive staining for the intracellular form of TGF-β1 was 100% for normal epithelium, 73.3% for CIN, and 44.1% for invasive carcinomas (P = 0.002). Percent positive staining for the extracellular form of TGF-β1 was 63.6% for stroma underlying normal epithelium, 60% for stroma associated with CIN, and 94.1% for stroma surrounding invasive cancer (P = 0.007). CONCLUSIONS. Decreased expression of intracellular TGF-β1 in neoplastic epithelium and increased expression of extracellular TGF-β1 in stroma associated with invasive cervical carcinoma suggest that an early event in the neoplastic transformation of cervical epithelial cells may involve the loss of TGF-β1. Tumor progression may be indirectly promoted by TGF-β1 secreted into or produced by supporting stromal elements.
AB - BACKGROUND. Transforming growth factor-β1 (TGF-β1) is a potent growth inhibitor of epithelial cell growth, but can also stimulate stromal cell growth. Loss of responsiveness to TGF-β1 or loss of TGF-β1 itself may be important in the progression of cervical intraepithelial neoplasia (CIN) to invasive cervical carcinoma. METHODS. To examine the expression of TGF-β in early stages of malignant transformation of the uterine cervix, paraffin embedded tissue samples from 11 patients with normal cervical epithelium, 15 with CIN I-III, 12 with microinvasive, and 18 with invasive squamous cell carcinoma were examined using an immunohistochemical technique. Tissues were immunostained with polyclonal antibodies that react with intracellular and extracellular forms of TGF-β1. RESULTS. Percent positive staining for the intracellular form of TGF-β1 was 100% for normal epithelium, 73.3% for CIN, and 44.1% for invasive carcinomas (P = 0.002). Percent positive staining for the extracellular form of TGF-β1 was 63.6% for stroma underlying normal epithelium, 60% for stroma associated with CIN, and 94.1% for stroma surrounding invasive cancer (P = 0.007). CONCLUSIONS. Decreased expression of intracellular TGF-β1 in neoplastic epithelium and increased expression of extracellular TGF-β1 in stroma associated with invasive cervical carcinoma suggest that an early event in the neoplastic transformation of cervical epithelial cells may involve the loss of TGF-β1. Tumor progression may be indirectly promoted by TGF-β1 secreted into or produced by supporting stromal elements.
KW - cervical cancer
KW - cervical dysplasia
KW - neoplastic transformation
KW - transforming growth factor-β1
UR - http://www.scopus.com/inward/record.url?scp=0029925083&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029925083&partnerID=8YFLogxK
U2 - 10.1002/(SICI)1097-0142(19960315)77:6<1107::AID-CNCR16>3.0.CO;2-5
DO - 10.1002/(SICI)1097-0142(19960315)77:6<1107::AID-CNCR16>3.0.CO;2-5
M3 - Article
C2 - 8635131
AN - SCOPUS:0029925083
SN - 0008-543X
VL - 77
SP - 1107
EP - 1114
JO - Cancer
JF - Cancer
IS - 6
ER -